Brigette Roberts

Brigette Roberts

Chief Executive Officer at IRULYA THERAPEUTICS INC.

Net worth: - $ as of 2026-09-29

50 year
Finance
Health Technology
Consumer Services

Profile

Dr. Brigette M.
Roberts, MD, is a Chief Executive Officer & Director at IRulya Therapeutics, Inc. and a Chief Executive Officer & Director at OrphAI Therapeutics, Inc. She is on the Board of Directors at IRulya Therapeutics, Inc. and OrphAI Therapeutics, Inc. Dr. Roberts was previously employed as a Principal by Nomura Securities International, Inc., a Founder by YYC Capital Management LLC, a Principal by Third Point Management Co. LLC, a Principal by Sturzas Institutional Research, Inc., and an Associate by Thomas Weisel Partners LLC.
She also served on the board at Ligand Pharmaceuticals, Inc. She received her undergraduate degree from Harvard University and a doctorate degree from New York University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-17 0 ( -.--% ) - $ 2026-09-29

Brigette Roberts active positions

CompaniesPositionStart
IRULYA THERAPEUTICS INC. Chief Executive Officer 2026-10-07
Chief Executive Officer 2021-01-31

Former positions of Brigette Roberts

CompaniesPositionEnd
Corporate Officer/Principal 2012-11-30
Founder 2011-12-31
Portfolio Manager-Equities -
LIGAND PHARMACEUTICALS INCORPORATED Director/Board Member 2007-02-28
Corporate Officer/Principal 2002-12-31
See the detail of Brigette Roberts's experience

Education of Brigette Roberts

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

96

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Finance

Consumer Services

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Brigette Roberts